Affiliations: [a] Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Italy
| [b] Neurology Unit and Human TSE Regional Center, ASL TO2 Maria Vittoria Hospital, Turin, Italy
| [c] UOC Neurologia, ASMN-IRRCS Reggio Emilia, Italy
| [d] IRCCS Don Gnocchi, Florence, Italy
| [e] ASO Neurologia, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy
Correspondence:
[*]
Correspondence to: Benedetta Nacmias, Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Italy Viale Pieraccini 6, 50139 Florence, Italy. Tel.: +390557948910; Fax: +390552758265; E-mail: [email protected].
Abstract: Background:During the twentieth century, frontotemporal dementia (FTD) was often misdiagnosed, confused with Alzheimer’s disease or psychiatric disorders, jeopardizing care and research. Objective:To analyze the FTD genes in the DNA samples of patients belonging to families clinically classified as probable Alzheimer’s disease (FAD) in the early 1990s and not carrying mutation in the three main genes linked to FAD (Presenilin 1, Presenilin 2, and Amyloid precursor protein). Methods:The genetic screening was performed on 63 probands diagnosed as FAD before the early 2000s. Results:Four patients out of the 63 studied (4/63, 6.3%) resulted as carrying four different GRN genetic variations: p.T272SfsX10, p.R110X, p.C149LfsX10, and p.W304C. The first two mutations (p.T272SfsX10, p.R110X) are the most frequent ones in Italy in FTD patients; the latter two (p.C149LfsX10 and p.W304C) are not described in the scientific literature. Conclusion:Our data suggest that it can be important to re-examine FAD patients diagnosed when the FTD spectrum was not well recognized and the causative FTD genes had not yet been identified. Moreover, we propose initially analyzing genes associated with the first form of suspected dementia and, if the results are negative, studying genes implicated in the other form of dementia.
